The Claim
In women with Hashimoto's thyroiditis, weekly supplementation with 50,000 IU of cholecalciferol for three months is associated with a significant increase in transforming growth factor-beta (TGFβ) gene expression, and this change is not significantly different from placebo.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In women with Hashimoto's thyroiditis, taking 50,000 IU of vitamin D weekly for three months increases TGFβ gene expression, but this increase is not statistically different from what occurs with a placebo.
See the scientific wording
In women with Hashimoto's thyroiditis, weekly supplementation with 50,000 IU of cholecalciferol for three months is associated with a significant increase in transforming growth factor-beta (TGFβ) gene expression, suggesting a potential shift toward immune regulation, though this change was not significantly different from placebo.
When vitamin D enters immune cells, it turns on genes that stop the production of inflammatory signals and start making a signal that calms the immune system, leading to more immune cells that suppress autoimmunity.
What the research says
1 studyTaking vitamin D didn't make TGFβ levels go up more than taking a sugar pill — so the vitamin D didn't really cause the increase, even though both groups saw some change.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.